Glenmark Pharma gets USFDA nod for Theophylline extended-release tablets

Glenmark

Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (USFDA) for Theophylline ExtendedRelease Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent to the reference listed drug, Theophylline Extended-Release Tablets, 300 mg and 450 mg, of Alembic Pharmaceuticals Limited.

Glenmark Pharma was quoting at Rs 617.00, up Rs 0.75, or 0.12 percent on the BSE.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from bigprofitbuzz.com.

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button